GEN1029

HexaBody-DR5/DR5 · Genmab

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for GEN1029, covering 2022-12-12 to 2022-12-12. Get the full timeline:

Most recent: Clinical Trial Update: GEN1029 (HexaBody®-DR5/DR5) Safety Trial in Patients With Malignant Solid Tumors [Phase 1, Phase 2]